RAB28 antibodies are immunological tools designed to detect and study the small GTPase RAB28, a member of the RAS oncogene family. These antibodies enable researchers to investigate RAB28's roles in intracellular trafficking, ciliary function, and disease pathogenesis, particularly in photoreceptor biology and ciliopathies .
RAB28 antibodies confirmed colocalization with ESCRT I (Vps23) and retromer (Vps26) complexes.
RNAi-mediated RAB28 depletion disrupted lysosomal cargo delivery and increased cell survival under stress .
Zebrafish rab28 mutants showed defective outer segment shedding, implicating RAB28 in retinal phagocytosis .
In humans, RAB28 antibodies identified splice variants critical for cone-rod dystrophy pathology .
RAB28 antibodies revealed its BBSome-dependent localization to periciliary membranes.
Loss of RAB28 led to ectopic EV accumulation, suggesting a role in EV biogenesis suppression .
Specificity: Antibodies validated using knockout controls (e.g., T. brucei RNAi lines) .
Cross-Reactivity: Confirmed in human, mouse, rat, and zebrafish models .
Functional Assays: Used to assess RAB28’s GTPase activity and interaction partners (e.g., PDE6D) .